And p-PRAS40-Thr246, a highly specific and stable effector molecule downstream of PI3K/AKT signaling pathway, can predict the sensitivity of prostate cancer cells and triple-negative breast cancer cells to AKT inhibitors, and also affect the prognosis of gastric cancer (9, 10). Here, AKT1S1 is linked to triple-negative breast carcinoma.